Robertson Global Health Solutions reports completion of name change and reverse stock split

NewsGuard 100/100 Score

Robertson Global Health Solutions Corporation (the "Company") (OTCBB:ASITD) announced today that it has formally completed its name change along with a 1 for 15 reverse stock split resulting in 11,543,346 shares of common stock currently issued and outstanding with 20,000,000 shares, par value $0.001, authorized. The Company also has 1,000,000 shares of preferred stock authorized, par value $0.001, with no preferred shares outstanding.

Filings with the Nevada Secretary of State and acceptance by FINRA of the name change and reverse split reflect the final steps connected with the May 28, 2010 reverse merger and recapitalization among ASI Technology Corporation (renamed Robertson Global Health Solutions Corporation) and NxOpinion, LLC ("NxOpinion"), a privately-owned health care technology licensing company headquartered in Saginaw, Michigan. As a result of the merger, the business of NxOpinion, is now owned by Robertson Health Services, Inc. ("RHS"), a wholly-owned subsidiary of the Company.

"With the previously announced name change and reverse stock split officially complete, we are now in a position to more clearly communicate our business and financial information," said Dr. Joel Robertson, Chairman and CEO. "We employ high-level intelligence oriented software to provide a comprehensive predictive diagnostic solution for global healthcare delivery. We look forward to communicating future business developments and progress to our stockholders and the investment community under the Robertson Health name."

Source:

Robertson Global Health Solutions Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into Chaga mushroom's mechanisms for fighting oral cancer